APA (7th ed.) Citation

JA, M., M, M., MH, E., TM, K., JP, M., & TE, L. (2020). Effects of caspofungin, tolcapone and other FDA-approved medications on MRSA susceptibility to vancomycin. Journal of global antimicrobial resistance, 22, 283. https://doi.org/10.1016/j.jgar.2020.03.014

Chicago Style (17th ed.) Citation

JA, Moore, Meakin M, Earl MH, Kummer TM, McAleer JP, and Long TE. "Effects of Caspofungin, Tolcapone and Other FDA-approved Medications on MRSA Susceptibility to Vancomycin." Journal of Global Antimicrobial Resistance 22 (2020): 283. https://doi.org/10.1016/j.jgar.2020.03.014.

MLA (9th ed.) Citation

JA, Moore, et al. "Effects of Caspofungin, Tolcapone and Other FDA-approved Medications on MRSA Susceptibility to Vancomycin." Journal of Global Antimicrobial Resistance, vol. 22, 2020, p. 283, https://doi.org/10.1016/j.jgar.2020.03.014.